← Product Code [GZB](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZB) · K030118

# RAPID PROGRAMMAR (K030118)

_Advanced Neuromodulation Systems · GZB · Mar 11, 2003 · Neurology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZB/K030118

## Device Facts

- **Applicant:** Advanced Neuromodulation Systems
- **Product Code:** [GZB](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZB.md)
- **Decision Date:** Mar 11, 2003
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 882.5880
- **Device Class:** Class 2
- **Review Panel:** Neurology
- **Attributes:** Software as a Medical Device

## Indications for Use

The ANS Neurostimulation system is indicated for Spinal Cord Stimulation (SCS) in the treatment of chronic pain of trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. The Rapid Programmer is intended to assist clinicians in determining the optimum performance while automatically logging procedures data. Rapid Programmer also allows the clinician to optimize performance by leading the patient through a series of device parameter combinations and recording the stimulation effects. This system uses a touch screen computer to program the stimulator to the required waveforms and electrode configurations and to log the information derived.

## Device Story

Rapid Programmer is a touch-screen computer system used by clinicians to configure and optimize ANS Neurostimulation systems. It interfaces with the implanted stimulator to set waveforms and electrode configurations. The device guides clinicians through patient-specific parameter combinations, records stimulation effects, and automatically logs procedural data. By facilitating systematic parameter adjustment, it assists in identifying optimal stimulation settings for chronic pain management. Used in clinical settings, it streamlines the programming workflow and maintains a record of device settings and patient responses.

## Clinical Evidence

No clinical data provided; bench testing only.

## Technological Characteristics

Touch-screen computer interface; software-based parameter configuration and data logging; intended for use with implanted spinal cord stimulators; Class II device (21 CFR 882.5880).

## Regulatory Identification

An implanted spinal cord stimulator for pain relief is a device that is used to stimulate electrically a patient's spinal cord to relieve severe intractable pain. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

This is a test document. Please ignore.

4/28/03

---

**Source:** [https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZB/K030118](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/GZB/K030118)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com